Clinical Trial Update: Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial of tebentafusp for metastatic uveal melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Tebentafusp (tebentafusp)

Snippet

Sponsor: Grupo Español Multidisciplinar de Melanoma | Conditions: Mestastatic Uveal Melanoma | Phase 2 | Status: RECRUITING